Atlas Trials

Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome

Clinical trial NCT04819269 · COMPLETED

Trial details

NCT number
NCT04819269
Sponsor
Sylentis, S.A.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dry Eye DiseaseSjögren Syndrome
Start date
2021-05-25
Primary completion
2023-12-11
Enrollment
203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.